Center for Scientific Review; Notice of Closed Meetings, 8801-8802 [E9-3944]
Download as PDF
Federal Register / Vol. 74, No. 37 / Thursday, February 26, 2009 / Notices
Explanation for Burden Estimates:
The burden estimates for tables I and
II of this document are based on FDA’s
experience with voluntary recalls under
part 810 of the regulations. FDA expects
no more than two mandatory recalls per
year, as most recalls are done
voluntarily. Since the last time this
collection of information was submitted
to OMB for renewal/approval, there
have been no mandatory recalls.
Dated: February 18, 2009.
Jeffrey Shuren,
Associate Commissioner for Policy and
Planning.
[FR Doc. E9–4137 Filed 2–25–09; 8:45 am]
BILLING CODE 4160–01–S
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of
Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of the following
meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Center for Scientific
Review Special Emphasis Panel Oral and
Dental: Small Business.
Date: March 5–6, 2009.
Time: 9 a.m. to 12 a.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892.
(Virtual Meeting).
Contact Person: Tamizchelvi Thyagarajan,
PhD, Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4016K,
MSC 7814, Bethesda, MD 20892, 301–451–
1327, tthyagar@csr.nih.gov.
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
Name of Committee: Center for Scientific
Review Special Emphasis Panel, Pathogens
and their Vectors.
Date: March 12, 2009.
Time: 10 a.m. to 5 p.m.
VerDate Nov<24>2008
16:56 Feb 25, 2009
Jkt 217001
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892.
(Virtual Meeting).
Contact Person: Richard G. Kostriken, PhD,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3192,
MSC 7808, Bethesda, MD 20892, 301–402–
4454, kostrikr@csr.nih.gov.
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
Name of Committee: Center for Scientific
Review Special Emphasis Panel Quick Trials
on Imaging and Image-guided Intervention.
Date: March 12, 2009.
Time: 11 a.m. to 3 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892.
(Virtual Meeting).
Contact Person: John Firrell, PhD,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5213,
MSC 7854, Bethesda, MD 20892, 301–435–
2598, firrellj@csr.nih.gov.
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
Name of Committee: Center for Scientific
Review Special Emphasis Panel, Infectious
Agent Detection/Diagnosis, Food Safety,
Sterilization/Disinfection and
Bioremediation.
Date: March 13, 2009.
Time: 8 a.m. to 6 p.m.
Agenda: To review and evaluate grant
applications.
Place: Doubletree Guest Suites Santa
Monica, 1707 Fourth Street, Santa Monica,
CA 90401.
Contact Person: Fouad A. El-Zaatari, PhD,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3206,
MSC 7808, Bethesda, MD 20814–9692, (301)
435–1149, elzaataf@csr.nih.gov.
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
Name of Committee: Center for Scientific
Review Special Emphasis Panel, Specials of
Genes, Genomes, and Genetics.
Date: March 13, 2009.
Time: 1 p.m. to 3 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892.
(Telephone Conference Call).
Contact Person: Michael A. Marino, PhD,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 2216,
MSC 7890, Bethesda, MD 20892, (301) 435–
0601, marinomi@csr.nih.gov.
This notice is being published less than 15
days prior to the meeting due to the timing
PO 00000
Frm 00029
Fmt 4703
Sfmt 4703
8801
limitations imposed by the review and
funding cycle.
Name of Committee: Center for Scientific
Review Special Emphasis Panel, BTSS
Member Conflict.
Date: March 16, 2009.
Time: 2 p.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892.
(Virtual Meeting).
Contact Person: Roberto J. Matus, MD,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5108,
MSC 7854, Bethesda, MD 20892, (301) 435–
2204, matusr@csr.nih.gov.
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
Name of Committee: Center for Scientific
Review Special Emphasis Panel, Member
Conflict: Immune Mechanisms.
Date: March 19, 2009.
Time: 1 p.m. to 4 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892.
(Telephone Conference Call).
Contact Person: Jian, Wang, PhD, Scientific
Review Officer, Center for Scientific Review,
National Institutes of Health, 6701 Rockledge
Drive, Room 4095D, MSC 7812, Bethesda,
MD 20892, (301) 435–2778,
wangjia@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel, Health of
the Population SBIR–2.
Date: March 23, 2009.
Time: 12 p.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892.
(Virtual Meeting).
Contact Person: Karin F. Helmers, PhD,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3148,
MSC 7770, Bethesda, MD 20892, 301–435–
1017, helmersk@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel Data
Ontologies and Sharing Data and Tools.
Date: March 24–25, 2009.
Time: 8 a.m. to 4:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892.
(Virtual Meeting).
Contact Person: Alexander Gubin, PhD,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Rm 5144, MSC
7812, Bethesda, MD 20892, 301–435–2902,
gubina@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel, Small
Business: Digestive Sciences.
Date: March 24–25, 2009.
Time: 8 a.m. to 6 p.m.
E:\FR\FM\26FEN1.SGM
26FEN1
8802
Federal Register / Vol. 74, No. 37 / Thursday, February 26, 2009 / Notices
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892.
(Virtual Meeting).
Contact Person: Bonnie L. Burgess-Beusse,
PhD, Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 2182,
MSC 7818, Bethesda, MD 20892, 301–435–
1783, beusseb@mail.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel Diversity
Fellowships: Division of Translational and
Clinical Sciences.
Date: March 24–25, 2009.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health. 6701
Rockledge Drive, Bethesda, MD 20892.
(Virtual Meeting).
Contact Person: John Firrell, PhD,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5213,
MSC 7854, Bethesda, MD 20892, 301–435–
2598, firrellj@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel,
Technologies in Cell Biology.
Date: March 24–25, 2009.
Time: 9 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892.
(Virtual Meeting).
Contact Person: Noni Byrnes, PhD,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5130,
MSC 7840, Bethesda, MD 20892, (301) 435–
1023, byrnesn@csr.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393–93.396, 93.837–93.844,
93.846–93.878, 93.892, 93.893, National
Institutes of Health, HHS)
Dated: February 18, 2009.
Jennifer Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. E9–3944 Filed 2–25–09; 8:45 am]
BILLING CODE 4140–01–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Substance Abuse and Mental Health
Services Administration
Agency Information Collection
Activities: Proposed Collection;
Comment Request
In compliance with Section
3506(c)(2)(A) of the Paperwork
Reduction Act of 1995 concerning
opportunity for public comment on
proposed collections of information, the
VerDate Nov<24>2008
16:56 Feb 25, 2009
Jkt 217001
Substance Abuse and Mental Health
Services Administration (SAMHSA)
will publish periodic summaries of
proposed projects. To request more
information on the proposed projects or
to obtain a copy of the information
collection plans, call the SAMHSA
Reports Clearance Officer on (240) 276–
1243.
Comments are invited on: (a) Whether
the proposed collections of information
are necessary for the proper
performance of the functions of the
agency, including whether the
information shall have practical utility;
(b) the accuracy of the agency’s estimate
of the burden of the proposed collection
of information; (c) ways to enhance the
quality, utility, and clarity of the
information to be collected; and (d)
ways to minimize the burden of the
collection of information on
respondents, including through the use
of automated collection techniques or
other forms of information technology.
Proposed Project: Rapid HIV Testing
Clinical Information Form for the
Minority AIDS Initiative (MAI) for
Ethnic and Racial Minorities at Risk for
Substance Use and HIV/AID—In Use
Without OMB Approval
The Substance Abuse and Mental
Health Services Administration’s
(SAMHSA) Center for Substance Abuse
Treatment (CSAT), is requesting an
OMB review and approval of the
Minority AIDS Initiative (MAI) Rapid
HIV Testing Clinical Information Form
that will be utilized for ethnic and racial
minority groups at risk for substance use
and HIV/AIDS that are served by
CSAT’s TCE–HIV grantees. The MAI
HIV Rapid Testing Clinical Information
Form would allow SAMHSA/CSAT to
collect essential clinical information
that will be used for quality assurance,
quality performance, and product
monitoring on approximately 30,000
rapid HIV test kits to be provided to
ethnic and racial minority communities
at no cost to the recipient provider
organizations. The MAI Rapid HIV
Testing Clinical Information Form
would support quality of care, provide
adequate clinical and product
monitoring, and provide appropriate
safeguards against fraud, waste and
abuse of Federal funds. SAMHSA’s
approach would avoid unnecessary
delay in informing any person
potentially adversely affected by a test
kit recall or public health advisory. This
program is authorized under Section
509 of the Public Health Service (PHS)
Act [42 U.S.C. 290bb–2].
The goals of SAMHSA’s MAI
initiative are to: (1) Increase the access
PO 00000
Frm 00030
Fmt 4703
Sfmt 4703
by racial and ethnic minority
communities to HIV testing, prevention,
care, and treatment services; (2)
implement strategies and activities
specifically targeted to the highest risk
and hardest-to-serve populations; (3)
reduce the stigma associated with HIV/
AIDS screening through outreach and
education, and (4) establish
collaborations or opportunities for
programs and/or activities to be
integrated.
The target populations for the
initiative are African Americans,
Hispanic/Latinos, and other racial and
ethnic minorities that are
disproportionately impacted by the twin
epidemics of HIV/AIDS and substance
abuse. Since 1981 approximately 1.7
million people are estimated to have
been infected with HIV in the U.S., and
more than 1.1 million are estimated to
be living with HIV/AIDS today. Racial
and ethnic minorities have been
disproportionately affected by HIV/
AIDS, and represent the majority of new
AIDS cases (70%), new HIV infections
(54%), prevalent HIV/AIDS cases (65%),
and AIDS deaths (72%) (CDC, 2006).
African Americans have been especially
affected by HIV/AIDS. More than half of
all new HIV infections and half of new
AIDS diagnoses occur in African
Americans despite their accounting for
approximately 12% of the U.S.
population. A similar impact exists
among Latinos, who represent 14% of
the U.S. population but account for 20%
of estimated AIDS diagnoses. Together,
Asian/Pacific Islanders and American
Indian/Alaska Natives represent 1%–
2% of new AIDS diagnoses.
The spread of HIV disease in the
United States has been partly fueled by
the use of illicit drugs. Injection drug
use (IDU) is directly related to HIV
transmission through the sharing of
drug equipment. According to CDC’s
latest report on 2006 rates, IDUs
accounted for 12 percent of estimated
new HIV infections. CDC’s historical
trend analysis indicates that new
infections have declined dramatically in
this population over time and confirm
the substantial evidence to date of
success in reducing HIV infections
among IDUs. Despite these declines,
rates of HIV and AIDS continue to rise
among certain groups including men
who have sex with men, high risk
heterosexual women and ethnic and
racial minority groups due to non-IDU
drugs and alcohol that interfere with
judgment about sexual and other types
of behaviors.
The estimated hour burden is
presented in the following table:
E:\FR\FM\26FEN1.SGM
26FEN1
Agencies
[Federal Register Volume 74, Number 37 (Thursday, February 26, 2009)]
[Notices]
[Pages 8801-8802]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E9-3944]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of Closed Meetings
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice is hereby given of the following
meetings.
The meetings will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: Center for Scientific Review Special Emphasis
Panel Oral and Dental: Small Business.
Date: March 5-6, 2009.
Time: 9 a.m. to 12 a.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 6701 Rockledge Drive,
Bethesda, MD 20892. (Virtual Meeting).
Contact Person: Tamizchelvi Thyagarajan, PhD, Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4016K, MSC 7814, Bethesda, MD
20892, 301-451-1327, tthyagar@csr.nih.gov.
This notice is being published less than 15 days prior to the
meeting due to the timing limitations imposed by the review and
funding cycle.
Name of Committee: Center for Scientific Review Special Emphasis
Panel, Pathogens and their Vectors.
Date: March 12, 2009.
Time: 10 a.m. to 5 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 6701 Rockledge Drive,
Bethesda, MD 20892. (Virtual Meeting).
Contact Person: Richard G. Kostriken, PhD, Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3192, MSC 7808, Bethesda, MD
20892, 301-402-4454, kostrikr@csr.nih.gov.
This notice is being published less than 15 days prior to the
meeting due to the timing limitations imposed by the review and
funding cycle.
Name of Committee: Center for Scientific Review Special Emphasis
Panel Quick Trials on Imaging and Image-guided Intervention.
Date: March 12, 2009.
Time: 11 a.m. to 3 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 6701 Rockledge Drive,
Bethesda, MD 20892. (Virtual Meeting).
Contact Person: John Firrell, PhD, Scientific Review Officer,
Center for Scientific Review, National Institutes of Health, 6701
Rockledge Drive, Room 5213, MSC 7854, Bethesda, MD 20892, 301-435-
2598, firrellj@csr.nih.gov.
This notice is being published less than 15 days prior to the
meeting due to the timing limitations imposed by the review and
funding cycle.
Name of Committee: Center for Scientific Review Special Emphasis
Panel, Infectious Agent Detection/Diagnosis, Food Safety,
Sterilization/Disinfection and Bioremediation.
Date: March 13, 2009.
Time: 8 a.m. to 6 p.m.
Agenda: To review and evaluate grant applications.
Place: Doubletree Guest Suites Santa Monica, 1707 Fourth Street,
Santa Monica, CA 90401.
Contact Person: Fouad A. El-Zaatari, PhD, Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3206, MSC 7808, Bethesda, MD
20814-9692, (301) 435-1149, elzaataf@csr.nih.gov.
This notice is being published less than 15 days prior to the
meeting due to the timing limitations imposed by the review and
funding cycle.
Name of Committee: Center for Scientific Review Special Emphasis
Panel, Specials of Genes, Genomes, and Genetics.
Date: March 13, 2009.
Time: 1 p.m. to 3 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 6701 Rockledge Drive,
Bethesda, MD 20892. (Telephone Conference Call).
Contact Person: Michael A. Marino, PhD, Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 2216, MSC 7890, Bethesda, MD
20892, (301) 435-0601, marinomi@csr.nih.gov.
This notice is being published less than 15 days prior to the
meeting due to the timing limitations imposed by the review and
funding cycle.
Name of Committee: Center for Scientific Review Special Emphasis
Panel, BTSS Member Conflict.
Date: March 16, 2009.
Time: 2 p.m. to 5 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 6701 Rockledge Drive,
Bethesda, MD 20892. (Virtual Meeting).
Contact Person: Roberto J. Matus, MD, Scientific Review Officer,
Center for Scientific Review, National Institutes of Health, 6701
Rockledge Drive, Room 5108, MSC 7854, Bethesda, MD 20892, (301) 435-
2204, matusr@csr.nih.gov.
This notice is being published less than 15 days prior to the
meeting due to the timing limitations imposed by the review and
funding cycle.
Name of Committee: Center for Scientific Review Special Emphasis
Panel, Member Conflict: Immune Mechanisms.
Date: March 19, 2009.
Time: 1 p.m. to 4 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 6701 Rockledge Drive,
Bethesda, MD 20892. (Telephone Conference Call).
Contact Person: Jian, Wang, PhD, Scientific Review Officer,
Center for Scientific Review, National Institutes of Health, 6701
Rockledge Drive, Room 4095D, MSC 7812, Bethesda, MD 20892, (301)
435-2778, wangjia@csr.nih.gov.
Name of Committee: Center for Scientific Review Special Emphasis
Panel, Health of the Population SBIR-2.
Date: March 23, 2009.
Time: 12 p.m. to 5 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 6701 Rockledge Drive,
Bethesda, MD 20892. (Virtual Meeting).
Contact Person: Karin F. Helmers, PhD, Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3148, MSC 7770, Bethesda, MD
20892, 301-435-1017, helmersk@csr.nih.gov.
Name of Committee: Center for Scientific Review Special Emphasis
Panel Data Ontologies and Sharing Data and Tools.
Date: March 24-25, 2009.
Time: 8 a.m. to 4:30 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 6701 Rockledge Drive,
Bethesda, MD 20892. (Virtual Meeting).
Contact Person: Alexander Gubin, PhD, Scientific Review Officer,
Center for Scientific Review, National Institutes of Health, 6701
Rockledge Drive, Rm 5144, MSC 7812, Bethesda, MD 20892, 301-435-
2902, gubina@csr.nih.gov.
Name of Committee: Center for Scientific Review Special Emphasis
Panel, Small Business: Digestive Sciences.
Date: March 24-25, 2009.
Time: 8 a.m. to 6 p.m.
[[Page 8802]]
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 6701 Rockledge Drive,
Bethesda, MD 20892. (Virtual Meeting).
Contact Person: Bonnie L. Burgess-Beusse, PhD, Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 2182, MSC 7818, Bethesda, MD
20892, 301-435-1783, beusseb@mail.nih.gov.
Name of Committee: Center for Scientific Review Special Emphasis
Panel Diversity Fellowships: Division of Translational and Clinical
Sciences.
Date: March 24-25, 2009.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health. 6701 Rockledge Drive,
Bethesda, MD 20892. (Virtual Meeting).
Contact Person: John Firrell, PhD, Scientific Review Officer,
Center for Scientific Review, National Institutes of Health, 6701
Rockledge Drive, Room 5213, MSC 7854, Bethesda, MD 20892, 301-435-
2598, firrellj@csr.nih.gov.
Name of Committee: Center for Scientific Review Special Emphasis
Panel, Technologies in Cell Biology.
Date: March 24-25, 2009.
Time: 9 a.m. to 5 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 6701 Rockledge Drive,
Bethesda, MD 20892. (Virtual Meeting).
Contact Person: Noni Byrnes, PhD, Scientific Review Officer,
Center for Scientific Review, National Institutes of Health, 6701
Rockledge Drive, Room 5130, MSC 7840, Bethesda, MD 20892, (301) 435-
1023, byrnesn@csr.nih.gov.
(Catalogue of Federal Domestic Assistance Program Nos. 93.306,
Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393-93.396, 93.837-93.844, 93.846-93.878, 93.892, 93.893,
National Institutes of Health, HHS)
Dated: February 18, 2009.
Jennifer Spaeth,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. E9-3944 Filed 2-25-09; 8:45 am]
BILLING CODE 4140-01-M